-
1
-
-
4644330119
-
European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG)
-
European Germ Cell Cancer Consensus Group
-
Schmoll H.J., Souchon R., Krege S., et al. European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004, 15:1377-1399. European Germ Cell Cancer Consensus Group.
-
(2004)
Ann Oncol
, vol.15
, pp. 1377-1399
-
-
Schmoll, H.J.1
Souchon, R.2
Krege, S.3
-
2
-
-
0030857028
-
Testicular germ-cell cancer
-
Bosl G.J., Motzer R.J. Testicular germ-cell cancer. N Engl J Med 1997, 337:242-253.
-
(1997)
N Engl J Med
, vol.337
, pp. 242-253
-
-
Bosl, G.J.1
Motzer, R.J.2
-
3
-
-
0031037241
-
International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers
-
International Germ Cell Cancer Collaborative Group
-
International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997, 15:594-603. International Germ Cell Cancer Collaborative Group.
-
(1997)
J Clin Oncol
, vol.15
, pp. 594-603
-
-
-
4
-
-
0025875021
-
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol
-
Nichols C.R., Williams S.D., Loehrer P.J., et al. Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 1991, 9:1163-1172.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1163-1172
-
-
Nichols, C.R.1
Williams, S.D.2
Loehrer, P.J.3
-
5
-
-
0344806946
-
Cisplatin, etoposide, and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: Final analysis of an intergroup trial
-
Hinton S., Catalano P.J., Einhorn L.H., et al. Cisplatin, etoposide, and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: Final analysis of an intergroup trial. Cancer 2003, 97:1869-1875.
-
(2003)
Cancer
, vol.97
, pp. 1869-1875
-
-
Hinton, S.1
Catalano, P.J.2
Einhorn, L.H.3
-
6
-
-
33846259793
-
Genito-Urinary Group of the French Federation of Cancer Centers (GETUG). Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumors: Mature results of a randomized trial
-
Droz J.P., Kramar A., Biron P., et al. Genito-Urinary Group of the French Federation of Cancer Centers (GETUG). Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumors: Mature results of a randomized trial. Eur Urol 2007, 51:739-746.
-
(2007)
Eur Urol
, vol.51
, pp. 739-746
-
-
Droz, J.P.1
Kramar, A.2
Biron, P.3
-
7
-
-
33846917709
-
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
-
Motzer R.J., Nichols C.J., Margolin K.A., et al. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 2007, 25:247-256.
-
(2007)
J Clin Oncol
, vol.25
, pp. 247-256
-
-
Motzer, R.J.1
Nichols, C.J.2
Margolin, K.A.3
-
8
-
-
0027996483
-
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors
-
Motzer R.J., Bajorin D.F., Schwartz L.H., et al. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1994, 12:2277-2283.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2277-2283
-
-
Motzer, R.J.1
Bajorin, D.F.2
Schwartz, L.H.3
-
9
-
-
0030052587
-
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
-
Bokemeyer C., Beyer J., Metzner B., et al. Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 1996, 7:31-34.
-
(1996)
Ann Oncol
, vol.7
, pp. 31-34
-
-
Bokemeyer, C.1
Beyer, J.2
Metzner, B.3
-
10
-
-
0032055188
-
A phase II trial of paclitaxel in refractory germ cell tumors
-
Sandler A.B., Cristou A., Fox S., et al. A phase II trial of paclitaxel in refractory germ cell tumors. Cancer 1998, 82:1381-1386.
-
(1998)
Cancer
, vol.82
, pp. 1381-1386
-
-
Sandler, A.B.1
Cristou, A.2
Fox, S.3
-
11
-
-
0028153260
-
Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: A rational approach to clinical protocol design
-
Chou T.C., Motzer R.J., Tong Y., et al. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: A rational approach to clinical protocol design. J Natl Cancer Inst 1994, 86:1517-1524.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 1517-1524
-
-
Chou, T.C.1
Motzer, R.J.2
Tong, Y.3
-
12
-
-
0033976336
-
Ifosfamide-based drug combinations: Preclinical evaluation of drug interactions and translation into the clinic
-
Vanhoefer U., Schleucher N., Klaassen U., et al. Ifosfamide-based drug combinations: Preclinical evaluation of drug interactions and translation into the clinic. Semin Oncol 2000, 27(1 Suppl 1):8-13.
-
(2000)
Semin Oncol
, vol.27
, Issue.1 SUPPL. 1
, pp. 8-13
-
-
Vanhoefer, U.1
Schleucher, N.2
Klaassen, U.3
-
13
-
-
0034126766
-
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer
-
Motzer R.J., Sheinfeld J., Mazumdar M., et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000, 18:2413-2418.
-
(2000)
J Clin Oncol
, vol.18
, pp. 2413-2418
-
-
Motzer, R.J.1
Sheinfeld, J.2
Mazumdar, M.3
-
14
-
-
27244441799
-
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
-
Kondagunta G.V., Bacik J., Donadio A., et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 2005, 23:6549-6555.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6549-6555
-
-
Kondagunta, G.V.1
Bacik, J.2
Donadio, A.3
-
15
-
-
14744287998
-
In vitro chemosensitivity test for human genito-urinary tumors using collagen gel matrix
-
Koshida K., Egawa M., Imao T., et al. In vitro chemosensitivity test for human genito-urinary tumors using collagen gel matrix. Int J Urol 2005, 12:67-72.
-
(2005)
Int J Urol
, vol.12
, pp. 67-72
-
-
Koshida, K.1
Egawa, M.2
Imao, T.3
-
16
-
-
0023739339
-
Single agent activity of methotrexate in advanced non-seminomatous testicular germ cell tumors
-
Smith D.B., Rustin G.J., Hitchins R., et al. Single agent activity of methotrexate in advanced non-seminomatous testicular germ cell tumors. Eur J Cancer Clin Oncol 1988, 24:1779-1781.
-
(1988)
Eur J Cancer Clin Oncol
, vol.24
, pp. 1779-1781
-
-
Smith, D.B.1
Rustin, G.J.2
Hitchins, R.3
-
17
-
-
0014142575
-
A chemotherapeutic approach to advanced testicular carcinoma
-
Wyatt J.K., McAninch L.N. A chemotherapeutic approach to advanced testicular carcinoma. Can J Surg 1967, 10:421-426.
-
(1967)
Can J Surg
, vol.10
, pp. 421-426
-
-
Wyatt, J.K.1
McAninch, L.N.2
-
18
-
-
0015326129
-
Chemotherapy for metastatic teratomas of the testis
-
Smithers D.W. Chemotherapy for metastatic teratomas of the testis. Br J Urol 1972, 44:217-228.
-
(1972)
Br J Urol
, vol.44
, pp. 217-228
-
-
Smithers, D.W.1
-
19
-
-
0031926303
-
New prospects for the treatment of germ-cell tumors
-
Droz J.P., Culine S. New prospects for the treatment of germ-cell tumors. Expert Opin Investig Drugs 1998, 7:1139-1157.
-
(1998)
Expert Opin Investig Drugs
, vol.7
, pp. 1139-1157
-
-
Droz, J.P.1
Culine, S.2
-
20
-
-
0032797317
-
Sixty percent salvage rate for germ-cell tumors using sequential m-BOP, surgery, and ifosfamide-based chemotherapy
-
Shamash J., Oliver R.T., Ong J., et al. Sixty percent salvage rate for germ-cell tumors using sequential m-BOP, surgery, and ifosfamide-based chemotherapy. Ann Oncol 1999, 10:685-692.
-
(1999)
Ann Oncol
, vol.10
, pp. 685-692
-
-
Shamash, J.1
Oliver, R.T.2
Ong, J.3
-
21
-
-
0344417927
-
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: The Spanish Germ-Cell Cancer Group experience (GG)
-
Germà-Lluch J.R., Garcia del Muro X., Tabernero J.M., et al. BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: The Spanish Germ-Cell Cancer Group experience (GG). Ann Oncol 1999, 10:289-293.
-
(1999)
Ann Oncol
, vol.10
, pp. 289-293
-
-
Germà-Lluch, J.R.1
Garcia del Muro, X.2
Tabernero, J.M.3
-
22
-
-
18444394311
-
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumors
-
Fizazi K., Prow D.M., Do K.A., et al. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumors. Br J Cancer 2002, 86:1555-1560.
-
(2002)
Br J Cancer
, vol.86
, pp. 1555-1560
-
-
Fizazi, K.1
Prow, D.M.2
Do, K.A.3
-
23
-
-
1042303683
-
The management and survival of patients with advanced germ-cell tumors: Improving outcome in intermediate and poor prognosis patients
-
Bhala N., Coleman J.M., Radstone C.R., et al. The management and survival of patients with advanced germ-cell tumors: Improving outcome in intermediate and poor prognosis patients. Clin Oncol (R Coll Radiol) 2004, 16:40-47.
-
(2004)
Clin Oncol (R Coll Radiol)
, vol.16
, pp. 40-47
-
-
Bhala, N.1
Coleman, J.M.2
Radstone, C.R.3
-
24
-
-
34547608744
-
GAMEC-a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
-
Shamash J., Powles T., Ansell W., et al. GAMEC-a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours. Br J Cancer 2007, 97:308-314.
-
(2007)
Br J Cancer
, vol.97
, pp. 308-314
-
-
Shamash, J.1
Powles, T.2
Ansell, W.3
-
25
-
-
0028339458
-
Synergistic action of taxol with tiazofurin and methotrexate in human breast cancer cells: Schedule-dependence
-
Yeh Y.A., Olah E., Wendel J.J., et al. Synergistic action of taxol with tiazofurin and methotrexate in human breast cancer cells: Schedule-dependence. Life Sci 1994, 54:PL431-PL435.
-
(1994)
Life Sci
, vol.54
-
-
Yeh, Y.A.1
Olah, E.2
Wendel, J.J.3
-
26
-
-
0032240948
-
Schedule dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines
-
Kano Y., Akutsu M., Tsunoda S., et al. Schedule dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines. Oncol Res 1998, 10:347-354.
-
(1998)
Oncol Res
, vol.10
, pp. 347-354
-
-
Kano, Y.1
Akutsu, M.2
Tsunoda, S.3
-
27
-
-
0034120074
-
Comparative study of sequential combinations of paclitaxel and methotrexate on a human bladder cancer cell line
-
Cos J., Bellmunt J., Soler C., et al. Comparative study of sequential combinations of paclitaxel and methotrexate on a human bladder cancer cell line. Cancer Invest 2000, 18:429-435.
-
(2000)
Cancer Invest
, vol.18
, pp. 429-435
-
-
Cos, J.1
Bellmunt, J.2
Soler, C.3
-
28
-
-
0036052170
-
Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer
-
Bellmunt J., Cos J., Clèries R., et al. Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer. Cancer Invest 2002, 20:673-685.
-
(2002)
Cancer Invest
, vol.20
, pp. 673-685
-
-
Bellmunt, J.1
Cos, J.2
Clèries, R.3
-
29
-
-
0030069958
-
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors
-
Huber M.H., Lee J.S., Newman R.A., et al. A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors. Ann Oncol 1996, 7:59-63.
-
(1996)
Ann Oncol
, vol.7
, pp. 59-63
-
-
Huber, M.H.1
Lee, J.S.2
Newman, R.A.3
-
30
-
-
78149369787
-
-
World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment (WHO Offset Publication No. 48,). Geneva, Switzerland: World Health Organization
-
World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment (WHO Offset Publication No. 48, 1979). Geneva, Switzerland: World Health Organization.
-
(1979)
-
-
-
31
-
-
0032703762
-
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis
-
Bokemeyer C., Kollmannsberger C., Meisner C., et al. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. J Clin Oncol 1999, 17:3450-3456.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3450-3456
-
-
Bokemeyer, C.1
Kollmannsberger, C.2
Meisner, C.3
-
32
-
-
0031943997
-
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: A Randomized Medical Research Council/European Organization for Research and Treatment of Cancer Study
-
Kaye S.B., Mead G.M., Fossa S., et al. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: A Randomized Medical Research Council/European Organization for Research and Treatment of Cancer Study. J Clin Oncol 1998, 16:692-701.
-
(1998)
J Clin Oncol
, vol.16
, pp. 692-701
-
-
Kaye, S.B.1
Mead, G.M.2
Fossa, S.3
-
33
-
-
0037364734
-
Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
-
Christian J.A., Huddart R.A., Norman A., et al. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors. J Clin Oncol 2003, 21:871-877.
-
(2003)
J Clin Oncol
, vol.21
, pp. 871-877
-
-
Christian, J.A.1
Huddart, R.A.2
Norman, A.3
-
34
-
-
0030839120
-
Treatment of men with metastatic non-seminomatous germ cell tumors with cyclical POMB/ACE chemotherapy
-
Bower M., Newlands E.S., Holden L., et al. Treatment of men with metastatic non-seminomatous germ cell tumors with cyclical POMB/ACE chemotherapy. Ann Oncol 1997, 8:477-483.
-
(1997)
Ann Oncol
, vol.8
, pp. 477-483
-
-
Bower, M.1
Newlands, E.S.2
Holden, L.3
-
35
-
-
0037505857
-
Paclitaxel, ifosfamide, and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer
-
Kawai K., Miyazaki J., Tsukamoto S., et al. Paclitaxel, ifosfamide, and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer. Jpn J Clin Oncol 2003, 33:127-131.
-
(2003)
Jpn J Clin Oncol
, vol.33
, pp. 127-131
-
-
Kawai, K.1
Miyazaki, J.2
Tsukamoto, S.3
-
36
-
-
0032735907
-
Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of Taxol-BEP
-
de Wit R., Louwerens M., de Mulder P.H., et al. Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of Taxol-BEP. Int J Cancer 1999, 83:831-833.
-
(1999)
Int J Cancer
, vol.83
, pp. 831-833
-
-
de Wit, R.1
Louwerens, M.2
de Mulder, P.H.3
-
37
-
-
38849124806
-
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): Results of the sCR2 international study
-
Fizazi K., Oldenburg J., Dunant A., et al. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): Results of the sCR2 international study. Ann Oncol 2008, 19:259-264.
-
(2008)
Ann Oncol
, vol.19
, pp. 259-264
-
-
Fizazi, K.1
Oldenburg, J.2
Dunant, A.3
-
38
-
-
0025894985
-
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma
-
Harstrick A., Schmoll H.J., Wilke H., et al. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. J Clin Oncol 1991, 9:1549-1555.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1549-1555
-
-
Harstrick, A.1
Schmoll, H.J.2
Wilke, H.3
-
39
-
-
0344734200
-
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor
-
Loehrer P.J., Gonin R., Nichols C.R., et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998, 16:2500-2504.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2500-2504
-
-
Loehrer, P.J.1
Gonin, R.2
Nichols, C.R.3
-
40
-
-
0031943040
-
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom
-
Fosså S.D., Kaye S.B., Mead G.M., et al. Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom. J Clin Oncol 1998, 16:716-724.
-
(1998)
J Clin Oncol
, vol.16
, pp. 716-724
-
-
Fosså, S.D.1
Kaye, S.B.2
Mead, G.M.3
|